TGF-β-dependent reprogramming of amino acid metabolism induces epithelial–mesenchymal transition in non-small cell lung cancers

Fumie Nakasuka,Sho Tabata,Takeharu Sakamoto,Akiyoshi Hirayama,Hiromichi Ebi,Tadaaki Yamada,Ko Umetsu,Maki Ohishi,Ayano Ueno,Hisatsugu Goto,Masahiro Sugimoto,Yasuhiko Nishioka,Yasuhiro Yamada,Masaru Tomita,Atsuo T. Sasaki,Seiji Yano,Tomoyoshi Soga

DOI: https://doi.org/10.1038/s42003-021-02323-7

IF: 6.548

2021-06-24

Communications Biology

Abstract:Abstract Epithelial–mesenchymal transition (EMT)—a fundamental process in embryogenesis and wound healing—promotes tumor metastasis and resistance to chemotherapy. While studies have identified signaling components and transcriptional factors responsible in the TGF-β-dependent EMT, whether and how intracellular metabolism is integrated with EMT remains to be fully elucidated. Here, we showed that TGF-β induces reprogramming of intracellular amino acid metabolism, which is necessary to promote EMT in non-small cell lung cancer cells. Combined metabolome and transcriptome analysis identified prolyl 4-hydroxylase α3 (P4HA3), an enzyme implicated in cancer metabolism, to be upregulated during TGF-β stimulation. Further, knockdown of P4HA3 diminished TGF-β-dependent changes in amino acids, EMT, and tumor metastasis. Conversely, manipulation of extracellular amino acids induced EMT-like responses without TGF-β stimulation. These results suggest a previously unappreciated requirement for the reprogramming of amino acid metabolism via P4HA3 for TGF-β-dependent EMT and implicate a P4HA3 inhibitor as a potential therapeutic agent for cancer.

biology